West has entered an agreement with Janssen Biotech for the development and manufacture of a new self-injection product. The technology, developed by Janssen, has been designed to facilitate easier self-injection of pharmaceutical and biologic drug products. West will market the new injection technology under the name SelfDose and will be responsible for co-development, commercial scale-up, and manufacture of the product.   “We are delighted to have formalized our relationship with Janssen Biotec...